Avantor, Inc.
Avantor, Inc. is a U.S.-based supplier of mission-critical products and services used across laboratory research, biopharmaceutical production, healthcare, education, government, and advanced technology applications. The company operates through two main businesses: Laboratory Solutions, which distributes consumables, equipment, and value-added lab services under the VWR brand, and Bioscience Production, which manufactures proprietary high-purity products such as J.T. Baker chemicals, Masterflex fluid handling systems, and NuSil silicone materials. Its model combines broad lab distribution with specialized manufacturing, allowing it to serve customers from early-stage research through scale-up and production. Avantor says it reaches more than 300,000 customer locations in about 180 countries and supports workflows with both digital channels and on-site service teams.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueBroadline distribution of consumables, equipment, and third-party lab products through the VWR channel.
J.T. Baker branded chemicals and process inputs used in bioprocessing and other regulated applications.
Masterflex tubing, pumps, and related fluid transfer products for research and industrial workflows.
NuSil high-purity silicone products, including customized materials for implants and aerospace uses.
Procurement, logistics, inventory management, cleanroom support, and other lab workflow services.
Products
Reported · share of revenue- Proprietary Materials and Consumables52.6 %
- Third Party Materials and Consumables47.4 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Avantor sells to customers that need reliable supply and tightly controlled quality in scientific and production workflows. Its largest end markets are biopharma and healthcare, education and government, and advanced technologies and applied materials, with products used from discovery through manufacturing. The company also serves laboratories and production sites that outsource procurement, inventory, and specialized support tasks to improve efficiency and compliance. Customer relationships are often long-lived, with about 45% of 2025 net sales coming from customers that had been with the company for 15 years or more.
Buys high-purity chemicals, consumables, and specialty materials for research, development, and regulated production.
Buys laboratory consumables, equipment, and services for academic and public-sector research environments.
Buys specialty materials and fluid handling products for semiconductor, aerospace, and industrial applications.
Purchases broadline lab products and outsourced procurement services through the VWR channel.
Buys NuSil silicone materials for implantable and other high-specification applications.
Strategy
Avantor’s strategy is to deepen its role in customer workflows by combining distribution, proprietary manufacturing, and on-site services. The company is investing in digital channels, with about 80% of transactions coming through digital platforms in 2025, to make procurement easier and more embedded in customer operations. It also continues to refine its portfolio, including divestitures and cost transformation actions, to improve focus and operating discipline. Long term, the company aims to broaden content in high-purity and regulated applications where technical requirements and customer switching costs are higher.
Digital ordering and embedded tools improve retention, lower transaction friction, and deepen customer dependence on Avantor.
Focusing on regulated, specification-driven products supports pricing power and more durable customer relationships.
The business has meaningful fixed manufacturing and distribution costs, so execution discipline is important when demand softens.
Geography
Avantor operates globally, with customer access in approximately 180 countries and sales activity across the Americas, Europe, and AMEA. The company highlights VWR as a strong distribution brand in the U.S. and Europe, while its manufacturing and supplier network is spread across multiple countries to support regulated supply chains. Geography matters because the business depends on local sales coverage, logistics execution, and compliance with country-specific technical and regulatory requirements. The company also notes that many of its tax, lease, and pension obligations are outside the United States, which adds cross-border operational and financial complexity.
Risks
Avantor is exposed to demand swings in laboratory and biopharma spending, and its 2025 results showed pressure from reduced customer demand in Laboratory Solutions. Because the company relies on manufacturing, distribution centers, logistics providers, and third-party suppliers, any disruption in operations or supply availability can delay shipments and hurt customer relationships. The business also faces cybersecurity and data protection risk as more transactions move through digital channels and as it uses AI-enabled tools and third-party service providers. In addition, the company carries significant goodwill and intangible assets, so weak operating performance or market deterioration can trigger impairment charges, while its global footprint creates tax, regulatory, and foreign exchange complexity.
- Demand slowdown in Laboratory SolutionsImpact: HighLikelihood: High
The company reported reduced customer demand in Laboratory Solutions, which directly affects its largest distribution-oriented business.
Exposure: Laboratory Solutions segment
- Manufacturing and logistics disruptionImpact: HighLikelihood: High
The business depends on timely production, shipping, and third-party logistics to serve regulated customers without interruption.
Exposure: Global manufacturing and distribution network
- Goodwill impairmentImpact: HighLikelihood: High
The company recorded a large goodwill impairment in 2025, showing sensitivity to share price, market conditions, and segment performance.
Exposure: Distribution reporting unit and acquired intangibles
- Cybersecurity and data protection failuresImpact: HighLikelihood: Medium
Digital ordering, customer-specific web tools, and third-party providers increase the attack surface and potential business interruption.
Exposure: E-commerce and internal systems
- Raw material and supplier concentrationImpact: MediumLikelihood: High
Some inputs are sole-sourced or tightly specified, so supplier failure or price inflation can affect margins and service levels.
Exposure
Accounting
Judgemental itemsA large portion of assets is tied to acquired goodwill and intangibles, and impairment testing can produce significant non-cash charges when market or operating assumptions weaken.
Impact: Can materially reduce reported earnings and asset values
The company operates in many jurisdictions and must estimate tax exposures, transfer pricing outcomes, and settlement probabilities.
Impact: Can affect tax expense, liabilities, and cash taxes
Future profitability by jurisdiction determines whether tax assets and loss carryforwards are realizable.
Impact: Can change reported tax benefits or charges
The business manufactures regulated products and also distributes third-party goods, so reserve estimates and production efficiency affect gross margin.
Impact: Can move gross profit and operating income
Portfolio changes such as the Clinical Services sale affect comparability and may create gains, adjustments, or discontinued operations-related impacts.
Impact: Can distort period-to-period revenue and earnings trends
Similar listed companies
Publicly listed companies with a comparable business focus.
Danaher Corporation
DHR · Industrial Instruments For Measurement, Display, and Control
Danaher is a U.S.-based science and technology company organized around biotechnology, life sciences, and diagnostics.
Bruker Corporation
BRKR · Laboratory Analytical Instruments
Bruker Corp designs, manufactures, and distributes high-performance scientific instruments and analytical and diagnostic solutions used to study life and…
Abbott Laboratories
ABT · Pharmaceutical Preparations
Abbott Laboratories is a U.S.-based healthcare company that discovers, develops, manufactures, and sells a diversified portfolio spanning medical devices,…
Baxter International Inc
BAX · Surgical & Medical Instruments & Apparatus
Bio-Rad Laboratories, Inc
BIO · Laboratory Analytical Instruments
Bio-Rad Laboratories is a U.S.-based multinational that develops, manufactures, and sells tools used in life science research and clinical diagnostics.
Ichor Holdings
ICHR · Semiconductors & Related Devices
Ichor Holdings designs and manufactures fluid delivery subsystems, gas delivery subsystems, and related precision components used in semiconductor capital equipment.
Last updated: 24/09/2026